Validation of a new prognostic model to predict short and medium-term survival in patients with liver cirrhosis

BMC Gastroenterology

Table 2 Cut-off values and accuracy of diagnostic models for liver-related survival for 3, 6 and 12 months for the entire cohort (n = 113)

Variable	Cut-off	Sensitivity	Specificity	PPV	NPV	Positive LR	Negative LR	Accuracy
3 M
MELD	15	0.80	0.75	0.13	0.99	3.17	0.27	0.75
MELD-Na	15	0.80	0.68	0.11	0.99	2.50	0.29	0.69
CreLiMAx	0.9	0.60	0.82	0.14	0.98	3.25	0.49	0.81
6 M
MELD	15	0.88	0.78	0.25	0.99	4.00	0.16	0.79
MELD-Na	15	0.89	0.72	0.23	0.99	3.16	0.15	0.73
CreLiMAx	0.9	0.56	0.84	0.25	0.95	3.56	0.53	0.82
12 M
MELD	15	0.69	0.80	0.35	0.94	3.46	0.38	0.79
MELD-Na	15	0.85	0.75	0.34	0.97	3.42	0.20	0.77
CreLiMAx	0.9	0.54	0.87	0.39	0.93	4.16	0.53	0.83

Creatinin-LiMAx risk score (CreLiMAx); months (M); model of end-stage liver disease (MELD); maximum liver function capacity (LiMAx); Likelihood ratio (LR); negative predictive value (NPV); positive predictive value (PPV)

ISSN: 1471-230X